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Association between post-hospital clinic
and telephone follow-up provider visits
with 30-day readmission risk in an
integrated health system
Huong Q. Nguyen1*, Aileen Baecker1, Timothy Ho2, Dan N. Huynh2, Heather L. Watson2, Jing Li3 and Ernest Shen1
Abstract
Background: Follow-up visits with clinic providers after hospital discharge may not be feasible for some patients
due to functional limitations, transportation challenges, need for physical distancing, or fear of exposure especially
during the current COVID-19 pandemic.
Methods: The aim of the study was to determine the effects of post-hospital clinic (POSH) and telephone (TPOSH)
follow-up provider visits versus no visit on 30-day readmission. We used a retrospective cohort design based on
data from 1/1/2017 to 12/31/2019 on adult patients (n = 213,513) discharged home from 15 Kaiser Permanente
Southern California hospitals. Completion of POSH or TPOSH provider visits within 7 days of discharge was the
exposure and all-cause 30-day inpatient and observation stay readmission was the primary outcome. We used
matching weights to balance the groups and Fine-Gray subdistribution hazard model to assess for readmission risk.
Results: Unweighted all-cause 30-day readmission rate was highest for patients who completed a TPOSH (17.3%)
followed by no visit (14.2%), non-POSH (evaluation and management visits that were not focused on the
hospitalization: 13.6%) and POSH (12.6%) visits. The matching weighted models showed that the effects of POSH
and TPOSH visits varied across patient subgroups. For high risk (LACE 11+) medicine patients, both POSH (HR: 0.77,
95% CI: 0.71, 0.85, P < .001) and TPOSH (HR: 0.91, 95% CI: 0.83, 0.99, P = .03) were associated with 23 and 9% lower
risk of 30-day readmission, respectively, compared to no visit. For medium to low risk medicine patients (LACE< 11)
and all surgical patients regardless of LACE score or age, there were no significant associations for either visit type
with risk of 30-day readmission.
Conclusions: Post-hospital telephone follow-up provider visits had only modest effects on 30-day readmission in
high-risk medicine patients compared to clinic visits. It remains to be determined if greater use and comfort with
virtual visits by providers and patients as a result of the pandemic might improve the effectiveness of these
encounters.
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Introduction
Transitional care management after hospital discharge
typically includes a follow-up provider clinic visit within
7–14 days depending on patient complexity [1, 2]. We
previously reported on the association between comple-
tion of a dedicated post-hospital (POSH) follow-up pro-
vider clinic visit with a 24% lower risk of 30-day
inpatient readmissions in older patients within an inte-
grated health system [3], a finding similar to other stud-
ies [4–6]. Nonetheless, since clinic visits were
challenging for high risk patients who have functional
limitations or no transportation, the health system began
offering telephone POSH (TPOSH) appointments as an
alternative to the clinic visits in 2015. Uptake of the
TPOSH was limited and comprised only 7% of the post-
discharge follow-up encounters prior to the COVID-19
pandemic.
In response to the dramatic shift to greater use of tele-
health for routine clinic appointments out of necessity
due to the COVID-19 pandemic [7], we aimed to ad-
vance the care transition evidence base by using data
prior to the public health emergency to examine the ef-
fects of clinic (POSH) and telephone (TPOSH) visits
completed within 7 days of discharge with a provider on
30-day inpatient and observation stay readmission com-
pared to no visit and whether these effects varied by age,
service line (medicine or surgical) and readmission risk
as secondary analyses. In contrast to our earlier report
[3], the analyses herein leverage a more contemporary
cohort that reflects secular changes in transitional care
management practices since 2014, is not restricted to
older adults, and is not adversely affected by the disrup-
tions in healthcare due to the COVID-19 pandemic.
Methods
Study design and sample
This retrospective cohort study included the first
hospitalization for all adult patients who were discharged
alive from 15 Kaiser Permanente Southern California
(KPSC) hospitals between January 1, 2017 to December
31, 2019 to home or home health and remained enrolled
in the health plan for at least 30 days post-discharge.
This study was approved by the KPSC Institutional Re-
view Board.
Transitional care management
Continuous performance improvement efforts across the
15 hospitals focused on ensuring that follow-up provider
visits were scheduled within 7 days of discharge for
medicine high risk patients as determined by a LACE
score [8] of 11 or higher during this study period; hospi-
tals with greater resources were encouraged to also
schedule appointments for medium risk (LACE score 7–
10) patients. Most POSH and TPOSH visits were
scheduled before hospital discharge with all sites consist-
ently achieving > 85% appointments scheduled for high
risk patients. TPOSH visits may be offered by hospital
scheduling staff to patients who they anticipated would
have challenges with completing a clinic POSH visit or
were offered by call center staff if patients reported that
they could not attend their POSH clinic appointment.
POSH/TPOSH visits were flagged for the provider as be-
ing a post-hospital follow-up visit in the electronic med-
ical record (EMR); reminders for routine care issues
were suppressed during these visits. Providers were
trained to focus on the post-discharge summary, medi-
cation review and issues that required follow-up. The
POSH and TPOSH visits were generally 20 min in
length. Other than the inability to conduct a physical as-
sessment during a TPOSH, providers were expected to
address standard transitional care needs of the patient.
The TPOSH/POSH may take place before or after a
standard 48–72-h post-discharge telephone call by an al-
lied health staff. A non-POSH visit could have been
scheduled before or after the hospitalization by the pa-
tient or a provider (primary care, specialist, and other
clinicians) for any reason, including evaluation and man-
agement; the focus of these visits was not specifically on
the hospitalization. Patients may have a follow-up visit
with specialty care as a result of the hospitalization but
due to challenges with access, these visits may not occur
within the first 7 days of discharge.
Covariates
Socio-demographic (age, gender, race/ethnicity, being
partnered), behavioral (no-show history in the last 12
months), social risk (receipt of medical financial assist-
ance from the health plan in the year prior to admis-
sion), and clinical characteristics [risk for readmission or
early death score based on length of stay, age, comorbid-
ities, and emergency department visits in the prior 6
months (LACE category [8]), severity of the index
hospitalization (LAPS2) [9], discharge disposition (home
vs. home health), service line (medicine vs. surgical),
functional status (non-ambulatory vs. ambulatory), falls
risk (Schmid [10] score of 3+) within 24 h of discharge,
and frailty category [11]] were obtained or calculated
from the electronic medical record (EMR) system.
Outcome
The primary outcome was all-cause 30-day inpatient or
observation stay readmission obtained from the EMR
and claims.
Statistical analysis
Although the rate of death in the overall sample was low
(1.5%), the higher rate among the TPOSH group (3.6%)
indicated a need to account for death as a competing
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risk, using the subdistribution hazard approach of Fine
and Gray [12]. We treated visit completion as a time-
dependent variable that could change in the first 7
days. While using time-varying covariates (i.e. visit
completion) with the Fine-Gray subdistribution hazard
model can preclude the estimation of their effect on
either the subdistribution hazard or cumulative inci-
dence function, visit completion as we defined it is
fixed for all subsequent risk sets, and so is not sub-
ject to this limitation [13].
We used matching weights [14] where the propensity
score (PS) were calculated using generalized boosted
models [15, 16] to address confounding instead of re-
gression adjustment, inverse probability of treatment
weights (IPTW) or matching approaches. We chose to
use matching weights for several reasons: 1) it provides
the average treatment effect on the treated (ATT) inter-
pretation of switching patients from one exposure group
to another (unlike IPTW which estimates average treat-
ment effects on the entire sample); 2) it mitigates the
bias that results from using IPTW when some groups
have extreme weights such as we observed for the
TPOSH group, in which case the substantial non-
overlap on the PS [17] results in a violation of the com-
mon support assumption, by effectively assigning those
with an extreme PS a weight close to 1; and 3) it avoids
the nuances and complexity of matching on three or
more groups to estimate the ATT, while also precluding
the need to either exclude some patients from a matched
analysis or introduce additional complexity by doing full
matching [14, 18].
Covariates that were meaningfully associated with ei-
ther visit completion or readmission [age, gender, race/
ethnicity, being partnered, no-show history in the last
12 months, receipt of medical financial assistance in the
year prior to admission (a marker of social risk), risk for
readmission or early death (LACE category [8]), severity
of hospitalization (LAPS2) [9], discharge disposition
(home vs. home health), service line (medicine vs. surgi-
cal), functional status (non-ambulatory vs. ambulatory)
and fall risk (Schmid [10] score of 3+) within 24 h of dis-
charge, frailty category [11], and hospital site] were in-
cluded in the multinomial regression models to estimate
propensity scores to construct the matching weights.
Such associations were deemed meaningful using a com-
bination of prior literature and examining statistical
measures of association (namely the maximum standard-
ized pairwise differences). Secondary subgroup analyses
were stratified by age (< 65 or 65+), service line (medi-
cine vs. surgical) and LACE score (< 11: medium to low
risk vs. 11+: high risk), to assess for heterogeneity of
treatments effects. Analyses were performed with SAS




The initial cohort of 390,365 adult, non-maternity pa-
tients discharged alive from 15 hospitals was pared down
to a total of 213,513 unique patients who had their first
index hospitalization during the study period after ex-
cluding 71,526 patients due to discharge disposition else-
where not to home or home health, 9115 patients not
enrolled for at least 30 days post discharge, and 96,211
patients with repeat hospitalizations during the study
period (Fig. 1).
Sample characteristics
Approximately 30% of patients completed a POSH (26%)
or TPOSH (4%) visit within 7-days of hospital discharge;
33% had a non-POSH visit and 37% did not have any
clinic visit (Tables 1 and 2). Approximately 57% of the
high-risk medicine LACE patients for whom the hospi-
tals prioritized for scheduling follow-up appointments
completed a POSH or TPOSH visit within 7 days
whereas 25% of the medium to low-risk medicine LACE
patients completed such visits. Patients who completed a
TPOSH tended to be older, had higher co-morbidities,
frailty and readmission risk compared to patients com-
pleting other visit types or no visit. Surgical patients
were more likely to complete nonPOSH visits or no visit
compared to medicine patients. The maximum stan-
dardized differences in matching weights across all
baseline variables were all < 0.10 indicating acceptable
balance across all six possible pairwise comparisons
(POSH vs. no visit, TPOSH vs. no visit, nonPOSH vs. no
visit, POSH vs. TPOSH, POSH vs. nonPOSH, TPOSH
vs. nonPOSH) [19].
A total of 29,288 (13.7%) and 3115 (1.5%) of patients
were readmitted or died within 30 days of being dis-
charged alive, respectively. Among those patients who
died within 30 days, 58% had a readmission prior to
death, while the remainder had a median survival time
of 13 days (IQR: 6, 21). The unweighted all-cause 30-day
readmission rate was highest for patients who completed
a TPOSH (17.3%) followed by no visit (14.2%), non-
POSH (13.6%) and POSH (12.6%) (Table 2).
Overall primary analyses
For all patients, only POSH (HR: 0.83, 95% CI: 0.77,
0.90, P < .001) provider visits completed within 7 days of
hospital discharge were associated with a 17% lower risk
of 30-day inpatient or observation readmission com-
pared to no visit in the weighted models (Table 3).
TPOSH provider visits were not associated with reduc-
tions in readmission risk for all patients (HR: 0.97, 95%
CI: 0.90, 1.05, P = .48). POSH provider visits were associ-
ated with 15% lower risk of 30-day readmission
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compared to TPOSH provider visits (HR: 0.85, 95% CI:
0.79, 0.93, P < .01).
Secondary subgroup analyses
For high risk (LACE 11+) medicine patients, both POSH
(HR: 0.77, 95% CI: 0.71, 0.85, P < .001) and TPOSH (HR:
0.91, 95% CI: 0.83, 0.99, P = .03) provider visits were as-
sociated with 23 and 9% lower risk of 30-day readmis-
sion, respectively, compared to no visit in the weighted
models. For medium to low risk patients (LACE< 11),
neither POSH (HR: 0.84, 95% CI: 0.67, 1.05, P = .12) nor
TPOSH (HR: 1.14, 95%CI: 0.94, 1.39, P = 0.19) provider
visits were associated with lower readmission risk com-
pared to no visit.
For all surgical patients regardless of LACE score or
age, there were no significant associations for any visit
type with risk of 30-day readmission in the weighted
models.
Discussion
Using a more contemporary and diverse cohort of pa-
tients discharged from hospital to home or home health,
we found that completion of either a clinic or telephone
provider follow-up visit within 7 days of discharge was
associated with lower 30-day readmission compared to
no visit only for high risk medicine patients. The risk re-
duction for POSH provider visits was comparable to our
previous report [3] while the TPOSH effects though sta-
tistically significant, were marginal at best. A surprising
finding was that none of the visit types were associated
with lower readmission for lower risk medicine and all
surgical patients.
Although the TPOSH was introduced to address a gap
for patients who have mobility and transportation chal-
lenges and who would otherwise not have any follow-up
provider visit, the limited effects of TPOSH compared to
POSH were not surprising for several reasons. Clinic
providers may have had insufficient practice with tele-
phonic transitional care management prior to the pan-
demic as demonstrated in the small volume of TPOSH
visits and may have been more cautious in directing pa-
tients to seek hospital-based care for worsening symp-
toms. Other ancillary team members were not able to
augment the provider’s care as they would during a
clinic visit. Neither physical exams nor visual assess-
ments were performed during these encounters and thus
providers were limited to patient and/or family self-
report. With as many as half of elderly hospitalized pa-
tients having cognitive impairment [20], and possibly,
without the assistance of a capable family member, gaps
in communication and early detection of decompensa-
tion may be problematic. Use of video and/or remote as-
sessments or biometrics could potentially enhance the
effectiveness of these telephone encounters, especially
for more complex, higher-risk older patients but only if
family can assist with these technologies [21, 22].
The COVID-19 pandemic has accelerated adoption of
digital technologies [7, 23] across all aspects of health
care, especially with physically-distanced care and the
earlier discharge of COVID-19 patients to increase hos-
pital capacity [24]. Learnings from use of digital home-
Fig. 1 Sample Flow
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Table 1 Baseline sample characteristics by completion of post-hospital follow-up provider visits within 7-days of discharge













Age 66.5 (16.4) 69.5 (16.2) 58.9 (17.8) 57.8 (18.6) 60.9 (18.1) 0.68 0.05
Female 27,203 (48.2%) 4857 (53.9%) 36,903 (52.7%) 45,197 (57.9%) 114,160 (53.5%) 0.10 0.01
Race/Ethnicity
Asian 5042 (8.9%) 721 (8%) 6432 (9.2%) 6459 (8.3%) 18,654 (8.7%) 0.01 0.00
Black 6440 (11.4%) 1446 (16.1%) 7434 (10.6%) 9146 (11.7%) 24,466 (11.5%) 0.05 0.01
Hispanic 18,788 (33.3%) 2517 (27.9%) 24,815 (35.5%) 28,760 (36.8%) 74,880 (35.1%) 0.09 0.01
Other 1041 (1.8%) 155 (1.7%) 1385 (2%) 1554 (2%) 4135 (1.9%) 0.00 0.00
White 25,072 (44.5%) 4170 (46.3%) 29,931 (42.8%) 32,205 (41.2%) 91,378 (42.8%) 0.05 0.01
Marital status: Partnered 32,842 (58.2%) 4622 (51.3%) 42,151 (60.2%) 44,166 (56.5%) 123,781 (58%) 0.09 0.01
Education: < College 41,216 (73.1%) 6504 (72.2%) 50,048 (71.5%) 56,640 (72.5%) 154,370 (72.3%) 0.09 0.05
Household income: >$20,000 48,602 (86.2%) 7667 (85.1%) 60,477 (86.4%) 67,187 (86.0%) 184,048 (86.2%) 0.15 0.06
Spoken language: English 48,993 (86.9%) 8108 (90%) 62,222 (88.9%) 69,453 (88.9%) 188,776 (88.4%) 0.03 0.02
Insurance typea
Commercial/private pay 21,503 (38.1%) 2772 (30.8%) 37,651 (53.8%) 43,070 (55.1%) 104,996 (49.2%) 0.24 0.02
Dual 3215 (5.7%) 591 (6.6%) 2450 (3.5%) 2907 (3.7%) 9163 (4.3%) 0.03 0.01
Medicaid 2493 (4.4%) 392 (4.4%) 3838 (5.5%) 4754 (6.1%) 11,477 (5.4%) 0.02 0.01
Medicare 29,160 (51.7%) 5250 (58.3%) 26,035 (37.2%) 27,330 (35%) 87,775 (41.1%) 0.23 0.02
Received medical financial assistance in prior year 4590 (8.1%) 941 (10.4%) 5163 (7.4%) 5035 (6.4%) 15,729 (7.4%) 0.04 0.00
Health and Behavior Before Hospitalization
Clinic no show rate (at least once) 34,084 (60.5%) 6185 (68.7%) 43,594 (62.3%) 47,297 (60.5%) 131,160 (61.4%) 0.08 0.01
Charlson comorbidity indexb 4.7 (3.08) 5.5 (3.14) 3.8 (2.99) 3.4 (2.94) 4.0 (3.07) 0.68 0.03
Myocardial infarction 9635 (17.1%) 1727 (19.2%) 7030 (10%) 6703 (8.6%) 25,095 (11.8%) – –
Congestive heart failure 13,396 (23.8%) 2684 (29.8%) 9295 (13.3%) 8613 (11%) 33,988 (15.9%) – –
Peripheral vascular disease 26,973 (47.8%) 5236 (58.1%) 22,050 (31.5%) 22,215 (28.4%) 76,474 (35.8%) – –
Cerebrovascular disease 12,175 (21.6%) 2358 (26.2%) 9105 (13%) 9833 (12.6%) 33,471 (15.7%) – –
Dementia 3536 (6.3%) 1134 (12.6%) 1940 (2.8%) 3357 (4.3%) 9967 (4.7%) – –
Rheumatic disease 3937 (7%) 710 (7.9%) 3692 (5.3%) 3711 (4.8%) 12,050 (5.6%) – –
Peptic ulcer disease 3779 (6.7%) 687 (7.6%) 3094 (4.4%) 3296 (4.2%) 10,856 (5.1%) – –
Mild liver disease 8727 (15.5%) 1499 (16.6%) 9095 (13%) 9301 (11.9%) 28,622 (13.4%) – –
Moderate or severe liver disease 1355 (2.4%) 236 (2.6%) 890 (1.3%) 837 (1.1%) 3318 (1.6%) – –
Diabetes without chronic complication 7821 (13.9%) 1159 (12.9%) 8766 (12.5%) 9464 (12.1%) 27,210 (12.7%) – –
Diabetes with chronic complication 18,284 (32.4%) 3201 (35.5%) 14,142 (20.2%) 12,878 (16.5%) 48,505 (22.7%) – –
Hemiplegia or paraplegia 2909 (5.2%) 740 (8.2%) 2211 (3.2%) 2721 (3.5%) 8581 (4%) – –
Renal disease 20,089 (35.6%) 3776 (41.9%) 14,696 (21%) 14,609 (18.7%) 53,170 (24.9%) – –
Any malignancy (lymphomas, leukemias etc) 8825 (15.7%) 1788 (19.8%) 11,963 (17.1%) 9563 (12.2%) 32,139 (15.1%) – –
Metastatic solid tumor 3343 (5.9%) 830 (9.2%) 4578 (6.5%) 3006 (3.8%) 11,757 (5.5%) – –
AIDS/HIV 236 (0.4%) 51 (0.6%) 281 (0.4%) 244 (0.3%) 812 (0.4%) – –
Frailty index 8.8 (6.65) 11.1 (8.35) 6.1 (6.05) 5.7 (6.44) 6.9 (6.65)
Low risk < 5 18,052 (32%) 2310 (25.6%) 37,893 (54.1%) 46,855 (60%) 105,110 (49.2%) 0.34 0.01
Intermediate risk 5–14 29,643 (52.6%) 4366 (48.5%) 26,225 (37.5%) 24,610 (31.5%) 84,844 (39.7%) 0.21 0.01
High Risk 15+ 8688 (15.4%) 2333 (25.9%) 5879 (8.4%) 6659 (8.5%) 23,559 (11%) 0.17 0.01
Values are presented as either mean (SD) or n (column %), unless otherwise indicated
POSH Post-hospital follow-up clinic visit, TPOSH Post-hospital follow-up telephone visit, nonPOSH visit not related to post-hospital follow-up
Wgtd Weighted maximum standardized differences across groups
a Missingness < 0.1
bWeighting only done on index, not individual conditions
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Table 2 Characteristics of the index hospitalization, 30-day readmission and mortality









n = 213,513 Not
Wgtd
Wgtd
All cause 30-day inpatient or observation
stay readmission
7093 (12.6%) 1562 (17.3%) 9540 (13.6%) 11,093 (14.2%) 29,288 (13.7%) – –
30-day mortality 605 (1.1%) 324 (3.6%) 683 (1.0%) 1503 (1.9%) 3115 (1.5%) – –
Index Hospitalization
Source of admissiona
Home/clinic 46,209 (82%) 7297 (81%) 60,593 (86.6%) 68,386 (87.5%) 182,485 (85.5%) 0.09 0.02
Hospital/SNF 9912 (17.6%) 1628 (18.1%) 8748 (12.5%) 9157 (11.7%) 29,445 (13.8%) 0.06 0.03
Other 204 (0.4%) 45 (0.5%) 608 (0.9%) 493 (0.6%) 1350 (0.6%) 0.01 0.00
Service line
Surgical 9775 (17.3%) 1773 (19.7%) 40,411 (57.7%) 48,886 (62.6%) 100,845 (47.2%) 0.45 0.03
Medicine 46,608 (82.7%) 7236 (80.3%) 29,586 (42.3%) 29,238 (37.4%) 112,668 (52.8%) – –
Major diagnostic categories (row %)
Diseases/Disorders of the Circulatory System 11,626 (37.6%) 1623 (5.2%) 10,512 (34%) 7173 (23.2%) 30,934 (14.5%) 0.11 0.05
Diseases/Disorders of the Musculoskeletal System 2421 (8.5%) 696 (2.5%) 9188 (32.4%) 16,049 (56.6%) 28,354 (13.3%) 0.16 0.05
Infectious & Parasitic Diseases, Systemic or
Unspecified Sites
11,584 (42.4%) 1845 (6.7%) 6574 (24%) 7343 (26.9%) 27,346 (12.8%) 0.11 0.04
Diseases/Disorders of the Digestive System 6672 (27.5%) 977 (4%) 7443 (30.7%) 9187 (37.8%) 24,279 (11.4%) 0.01 0.02
Diseases/Disorders of the Nervous System 4946 (33.2%) 595 (4%) 4431 (29.7%) 4940 (33.1%) 14,912 (7%) 0.02 0.03
Endocrine, Nutritional & Metabolic Diseases &
Disorders
1922 (15.4%) 362 (2.9%) 3528 (28.3%) 6635 (53.3%) 12,447 (5.8%) 0.05 0.01
Diseases/Disorders of the Respiratory System 4985 (40.7%) 822 (6.7%) 3111 (25.4%) 3317 (27.1%) 12,235 (5.7%) 0.05 0.02
Diseases/Disorders of the Hepatobiliary System 3212 (27.4%) 420 (3.6%) 3373 (28.7%) 4739 (40.4%) 11,744 (5.5%) 0.01 0.01
Laboratory Acute Physiology Score (LAPS2) 70.1 (30.42) 73.4 (31.94) 57.8 (27.98) 56.2 (28.43) 61.1 (29.66) 0.58 0.03
LACE readmission risk score 10.4 (2.80) 11.2 (2.93) 8.0 (3.59) 7.0 (3.66) 8.4 (3.70)
LACE < 11 26,301 (46.6%) 2810 (31.2%) 52,055 (74.4%) 64,181 (82.2%) 145,347 (68.1%) 0.51 0.02
LACE 11 to 15 28,897 (51.3%) 5787 (64.2%) 16,928 (24.2%) 12,997 (16.6%) 64,609 (30.3%) 0.48 0.04
LACE 16 to 19 1185 (2.1%) 412 (4.6%) 1014 (1.4%) 946 (1.2%) 3557 (1.7%) 0.03 0.01
Length of stay
0–3 days 29,460 (52.2%) 4044 (44.9%) 44,692 (63.8%) 57,202 (73.2%) 135,398 (63.4%) 0.28 0.05
4–6 days 17,659 (31.3%) 2998 (33.3%) 16,312 (23.3%) 14,789 (18.9%) 51,758 (24.2%) 0.14 0.04
7–13 days 7491 (13.3%) 1427 (15.8%) 7221 (10.3%) 4913 (6.3%) 21,052 (9.9%) 0.10 0.02
14+ days 1773 (3.1%) 540 (6%) 1772 (2.5%) 1220 (1.6%) 5305 (2.5%) 0.04 0.02
Functional status within 24 h of discharge
Non-ambulatory 6177 (11%) 2231 (24.8%) 7213 (10.3%) 11,525 (14.8%) 27,146 (12.7%) 0.14 0.01
Ambulatory with assistance 27,514 (48.8%) 4057 (45%) 27,458 (39.2%) 29,276 (37.5%) 88,305 (41.4%) 0.11 0.00
Ambulatory 21,965 (39%) 2569 (28.5%) 28,967 (41.4%) 30,000 (38.4%) 83,501 (39.1%) 0.13 0.01
Missing 727 (1.3%) 152 (1.7%) 6359 (9.1%) 7323 (9.4%) 14,561 (6.8%) 0.08 0.00
Schmid fall risk score 3+ within 24 h of discharge 9354 (16.6%) 2107 (23.4%) 11,882 (17%) 14,608 (18.7%) 37,951 (17.8%) 0.07 0.01
Discharge disposition
Home 36,726 (65.1%) 4755 (52.8%) 49,184 (70.3%) 55,429 (71%) 146,094 (68.4%) 0.18 0.01
Home health 19,657 (34.9%) 4254 (47.2%) 20,813 (29.7%) 22,695 (29%) 67,419 (31.6%) – –
Values are presented as either mean (SD) or n (column %), unless otherwise indicated
POSH Post-hospital follow-up clinic visit, TPOSH Post-hospital follow-up telephone visit, nonPOSH visit not related to post-hospital follow-up
Wgtd Weighted maximum standardized differences across groups
a Missingness < 0.1
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Table 3 Weighted models examining the effect of post-hospital follow-up provider visits completed within 7-days of discharge on
all cause 30-day inpatient and observation stay readmission stratified by age, service line, and readmission risk
All patients Age: 65+ Age < 65














POSH vs. no visit 1.34 (1.3, 1.38) 0.83 (0.77, 0.9) 1.17 (1.12, 1.22) 0.83 (0.76, 0.92) 1.38 (1.31, 1.46) 0.82 (0.71, 0.95)
TPOSH vs. no visit 1.85 (1.74, 1.95) 0.97 (0.9, 1.05) 1.51 (1.41, 1.62) 0.94 (0.86, 1.03) 2.10 (1.9, 2.32) 1.04 (0.92, 1.19)
nonPOSH vs. no visit 1.37 (1.33, 1.41) 1.05 (0.98, 1.13) 1.15 (1.11, 1.2) 1.08 (1.00, 1.18) 1.59 (1.53, 1.66) 0.98 (0.86, 1.12)
POSH vs. TPOSH 0.73 (0.68, 0.77) 0.85 (0.79, 0.93) 0.77 (0.72, 0.83) 0.89 (0.8, 0.98) 0.66 (0.59, 0.73) 0.79 (0.68, 0.91)
Medicine, n = 112,668
POSH vs. no visit 0.91 (0.88, 0.95) 0.79 (0.73, 0.86) 0.85 (0.81, 0.89) 0.81 (0.73, 0.89) 0.95 (0.89, 1.01) 0.75 (0.65, 0.88)
TPOSH vs. no visit 1.31 (1.23, 1.39) 0.95 (0.87, 1.02) 1.13 (1.05, 1.22) 0.93 (0.85, 1.02) 1.54 (1.38, 1.73) 0.98 (0.85, 1.13)
nonPOSH vs. no visit 1.14 (1.09, 1.18) 1.04 (0.96, 1.12) 1.11 (1.05, 1.17) 1.07 (0.98, 1.17) 1.19 (1.12, 1.26) 0.95 (0.82, 1.09)
POSH vs. TPOSH 0.7 (0.65, 0.74) 0.84 (0.77, 0.91) 0.75 (0.69, 0.80) 0.87 (0.78, 0.96) 0.61 (0.55, 0.69) 0.77 (0.65, 0.9)
LACE 11+ (High risk)
POSH vs. no visit 0.73 (0.69, 0.76) 0.77 (0.71, 0.85) 0.75 (0.71, 0.80) 0.79 (0.71, 0.88) 0.67 (0.62, 0.74) 0.72 (0.61, 0.86)
TPOSH vs. no visit 0.92 (0.86, 0.99) 0.91 (0.83, 0.99) 0.94 (0.87, 1.03) 0.92 (0.83, 1.02) 0.87 (0.76, 1.00) 0.87 (0.74, 1.03)
nonPOSH vs. no visit 0.99 (0.94, 1.04) 1.01 (0.93, 1.09) 1.04 (0.97, 1.11) 1.05 (0.96, 1.16) 0.89 (0.81, 0.97) 0.90 (0.77, 1.05)
POSH vs. TPOSH 0.79 (0.74, 0.85) 0.85 (0.77, 0.94) 0.80 (0.74, 0.87) 0.86 (0.77, 0.97) 0.78 (0.68, 0.89) 0.82 (0.69, 0.99)
LACE < 11 (Medium/low risk)
POSH vs. no visit 0.87 (0.82, 0.93) 0.84 (0.67, 1.05) 0.83 (0.76, 0.91) 0.86 (0.65, 1.15) 0.86 (0.78, 0.95) 0.79 (0.55, 1.13)
TPOSH vs. no visit 1.23 (1.06, 1.43) 1.14 (0.94, 1.39) 1.01 (0.83, 1.24) 1.02 (0.78, 1.33) 1.44 (1.15, 1.80) 1.32 (0.98, 1.78)
nonPOSH vs. no visit 1.21 (1.14, 1.29) 1.16 (0.96, 1.42) 1.16 (1.06, 1.27) 1.19 (0.92, 1.54) 1.27 (1.17, 1.39) 1.15 (0.85, 1.56)
POSH vs. TPOSH 0.71 (0.61, 0.82) 0.73 (0.58, 0.92) 0.82 (0.67, 1.01) 0.85 (0.63, 1.14) 0.59 (0.47, 0.75) 0.60 (0.42, 0.85)
All Surgical n = 100,845
POSH vs. no visit 1.35 (1.24, 1.46) 1.01 (0.8, 1.28) 1.21 (1.08, 1.35) 0.93 (0.69, 1.25) 1.34 (1.19, 1.51) 1.11 (0.76, 1.63)
TPOSH vs. no visit 1.68 (1.43, 1.96) 1.17 (0.94, 1.45) 1.48 (1.20, 1.83) 1.05 (0.79, 1.39) 1.68 (1.31, 2.15) 1.34 (0.94, 1.89)
nonPOSH vs. no visit 1.65 (1.57, 1.73) 1.07 (0.86, 1.34) 1.17 (1.08, 1.27) 1.01 (0.76, 1.36) 1.93 (1.82, 2.05) 1.18 (0.83, 1.67)
POSH vs. TPOSH 0.81 (0.68, 0.96) 0.87 (0.68, 1.10) 0.82 (0.65, 1.02) 0.89 (0.66, 1.20) 0.80 (0.61, 1.05) 0.83 (0.57, 1.21)
LACE 11+ (High risk)
POSH vs. no visit 0.73 (0.64, 0.84) 0.77 (0.56, 1.07) 0.75 (0.63, 0.89) 0.80 (0.54, 1.16) 0.72 (0.58, 0.89) 0.72 (0.39, 1.32)
TPOSH vs. no visit 1.11 (0.88, 1.38) 1.1 (0.82, 1.47) 1.12 (0.84, 1.48) 1.05 (0.74, 1.49) 1.11 (0.76, 1.62) 1.20 (0.71, 2.03)
nonPOSH vs. no visit 0.95 (0.84, 1.06) 0.95 (0.7, 1.29) 0.93 (0.8, 1.09) 0.97 (0.67, 1.41) 0.95 (0.80, 1.13) 0.90 (0.52, 1.55)
POSH vs. TPOSH 0.66 (0.53, 0.84) 0.7 (0.51, 0.97) 0.67 (0.50, 0.90) 0.76 (0.51, 1.12) 0.64 (0.44, 0.95) 0.60 (0.33, 1.07)
LACE < 11 (Medium/low risk)
POSH vs. no visit 1.21 (1.08, 1.36) 1.36 (0.96, 1.92) 1.21 (1.02, 1.43) 1.24 (0.76, 2.03) 1.14 (0.97, 1.34) 1.43 (0.87, 2.37)
TPOSH vs. no visit 1.3 (1.03, 1.65) 1.28 (0.91, 1.80) 1.22 (0.88, 1.70) 1.17 (0.72, 1.88) 1.27 (0.9, 1.80) 1.37 (0.84, 2.22)
nonPOSH vs. no visit 1.75 (1.66, 1.85) 1.30 (0.92, 1.82) 1.20 (1.09, 1.33) 1.17 (0.72, 1.92) 2.02 (1.9, 2.15) 1.42 (0.89, 2.27)
POSH vs. TPOSH 0.93 (0.72, 1.21) 1.06 (0.75, 1.49) 0.99 (0.69, 1.41) 1.07 (0.67, 1.70) 0.90 (0.62, 1.31) 1.05 (0.64, 1.73)
Values are presented as hazard ratio (HR) and 95% confidence intervals
POSH Post-hospital follow-up clinic visit, TPOSH Telephone post-hospital follow-up visit, nonPOSH Visit not related to post-hospital follow-up, LACE Length of stay;
Acuity of admission; Co-morbidities; Emergency visits in previous 6 months
Matching weights were used, based on multinomial propensity score models that included age, gender, race/ethnicity, being partnered, no-show history in the
last 12months, receipt of medical financial assistance in the year prior to admission (a marker of social risk), frailty category, risk for readmission or early death
(LACE category), severity of hospitalization (LAPS2), service line (medicine vs. surgical), functional status (non-ambulatory, ambulatory with assistance, or
ambulatory) and fall risk (Schmid score of 3+) within 24 h of discharge; disposition (home vs. home health), and hospital site
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monitoring technologies for transitional care with
COVID-19 patients could serve as exemplars for optimiz-
ing transitional care approaches for other medical condi-
tions in the future. Since the start of the pandemic
through December 2020, this health system conducted
87% of the transitional care management visits via tele-
phone, 3% by video, and 10% in person, a complete flip
compared to the pre-pandemic era. While there are no
other published reports specifically on virtual care transi-
tion management practices, Eberly et al. [25] reported a
more balanced distribution of video (45%) and telephone
(55%) primary and specialty care visits from a large aca-
demic health system from March to May 2020. We expect
that video visits will increase over time with greater pro-
vider comfort and increased patient access to technology
[26] and also due to telehealth reimbursement for Medi-
care Advantage plans which took effect in January 1, 2020
but the long-term future of telehealth reimbursement in
fee-for-service Medicare remains to be seen after the end
of the public health emergency [23].
The finding that completion of any follow-up visit
whether with a provider or ancillary care staff within 7
days of hospital discharge was not associated with lower
readmission risk compared to no visit for surgical pa-
tients merit more detailed analyses by types of surgical
procedures (high vs. low risk, planned vs. unplanned) to
determine the optimal timing and appropriate type of
provider follow-up post hospitalization in order to
maximize value for health systems and payers [27]. In
contrast to medicine patients, nearly half of the surgical
patients did not have an outpatient follow-up visit within
a week of discharge. It is possible that because the vast
majority (87%) of these patients were considered as
lower risk for readmission (LACE scores < 11), follow-up
visits were rightly not prioritized by the discharging pro-
viders as our analyses showed that these visits were not
associated with any added benefit in terms of risk
reduction.
Strengths of this study included use of a large, diverse
contemporary cohort that was exposed to many changes
in the care transition management practices in recent
years, replication of findings from our previous, limited
analyses of an older study cohort, ability to balance rele-
vant baseline covariates across comparison groups using
matching weights, and inclusion of both inpatient and ob-
servation stay readmissions as a primary outcome in an-
ticipation of changes to how readmissions are counted in
the Center for Medicare and Medicaid Services Hospital
Readmission Reduction Program as of January 1, 2021.
Limitations
Since this analysis was limited to patients discharged
from Kaiser Permanente hospitals to home, the findings
may not generalize to patients discharged to other
higher-level settings or in non-integrated care systems
where electronic records are not easily shared across
hospital and ambulatory care settings. The TPOSH vol-
ume was relatively small for several of the subgroups, es-
pecially for younger patients and those on the surgical
service, to obtain a reliable estimate of benefit or harm.
Since the care transition quality improvement efforts in
this health system did not distinguish across disease
states nor cause of the index admission except for medi-
cine vs. surgical, we did not explore additional subgroup
analyses in this paper though this should be the focus of
future study. The matching weights were balanced on
measured covariates but the cohorts may differ in other
ways; omission of unmeasured confounders such as ex-
posure to other care transition interventions and treat-
ment adherence, as well selection bias, are other notable
limitations of this observational study design. Nonethe-
less, prior studies of heart failure and COPD for in-
stance, have also reported an association between
completion of follow-up provider visits within 7 days
post-discharge and lower rates of 30-day readmission
[28, 29]. We did not account for the multiple compari-
sons in the subgroup analyses and thus some of the sta-
tistically significant findings may be spurious. However,
we were cautious with our interpretation of these results.
Finally, we were not able to assess the frequency of clin-
ical escalations associated with the TPOSH visits.
Conclusions
We found that completion of either a clinic or telephone
provider follow-up visit within 7 days of hospital
discharge was associated with lower 30-day inpatient or
observation readmission compared to no visit only for
high risk medicine patients. The effects of the telephone
provider follow-up, though statistically significant, were
marginal at best during the pre-pandemic era. It remains
to be determined if greater use and comfort with virtual
visits by providers and patients as a result of the
pandemic might improve the effectiveness of these en-
counters. The dramatic transformation of care delivery
to virtual care in response to the COVID-19 pandemic
offers an unprecedented opportunity to further examine
the right mix of in-person clinic or home-based and re-
mote care (telephone, video, and e-visits) for post-
hospital discharge follow-up across multiple relevant pa-
tient subgroups [30] to ensure equitable access to high
quality care transition services [25, 31, 32].
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